| Identification |
| Name: | Imidodicarbonimidicdiamide, N-butyl-, hydrochloride (1:1) |
| Synonyms: | Biguanide,1-butyl-, monohydrochloride (8CI); Imidodicarbonimidic diamide, N-butyl-,monohydrochloride (9CI); 1-Butylbiguanide hydrochloride; 1-Butylbiguanide,monohydrochloride; 1-Butyldiguanide hydrochloride; Andere; Biforon; Bigunal;Bufonamin; Buformin hydrochloride; Bulbonin; Diabrin; Dibetos; Glibutide;Gliporal; Glybutide; Insulamin; Krebon; N-Butylbiguanide hydrochloride;N1-Butyl-biguanide hydrochloride; N1-n-Butylbiguanide hydrochloride; Panformin;Sindiatil; Tidemol; Ziavetine |
| CAS: | 1190-53-0 |
| EINECS: | 214-723-6 |
| Molecular Formula: | C6H15 N5 . Cl H |
| Molecular Weight: | 157.2168 |
| InChI: | InChI=1S/C6H15N5/c1-2-3-4-10-6(9)11-5(7)8/h2-4H2,1H3,(H6,7,8,9,10,11) |
| Molecular Structure: |
 |
| Properties |
| Melting Point: | 174-177ºC |
| Water Solubility: | Freely sol in water, alcohol |
| Solubility: | Freely sol in water, alcohol |
| Usage: | Buformin, clinically used for diabetes mellitus, is known to improve resistance to insulin in patients. It suppresses the expression of glyceraldehyde 3-phosphate dehydrogenase. |
| Safety Data |
| |
 |
